Researchers showed that PERK plays a critical role in BRAF inhibitor-acquired resistance in melanoma with impaired PTEN.
[npj Precision Oncology]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Dermal Cell News PERK Mediates Resistance to BRAF Inhibition in Melanoma with Impaired PTEN
